SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH M impact

Bristol Myers Squibb’s 2026 adjusted EPS outlook includes net impact from acquired IPR&D charges and licensing

The 2026 adjusted EPS outlook range includes a net impact from acquired IPR&D charges and licensing income.

BMY

Related stories